Elevance Health Inc.

Symbol: ELV

NYSE

515.83

USD

Market price today

  • 20.0717

    P/E Ratio

  • -4.4705

    PEG Ratio

  • 120.02B

    MRK Cap

  • 0.01%

    DIV Yield

Elevance Health Inc. (ELV) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.90%

Operating Profit Margin

0.22%

Net Profit Margin

0.04%

Return on Assets

0.06%

Return on Equity

0.16%

Return on Capital Employed

0.56%

Company general description and statistics

Sector: Healthcare
Industry: Healthcare Plans
CEO:Ms. Gail Koziara Boudreaux
Full-time employees:104900
City:Indianapolis
Address:220 Virginia Avenue
IPO:2001-10-30
CIK:0001156039

Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.

General Outlook

When we look at how much money they make before expenses, they keep 0.897% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.221%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.036%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.056% return, is a testament to Elevance Health Inc.'s adeptness in optimizing resource deployment. Elevance Health Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.160%. Furthermore, the proficiency of Elevance Health Inc. in capital utilization is underscored by a remarkable 0.562% return on capital employed.

Stock Prices

Elevance Health Inc.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $527.87, while its low point bottomed out at $519.74. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Elevance Health Inc.'s stock market.

Liquidity Ratios

Analyzing ELV liquidity ratios reveals its financial health of the firm. The current ratio of 137.47% gauges short-term asset coverage for liabilities. The quick ratio (123.07%) assesses immediate liquidity, while the cash ratio (14.04%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio137.47%
Quick Ratio123.07%
Cash Ratio14.04%

Profitability Ratios

ELV profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 4.68% underscores its earnings before tax deductions. The effective tax rate stands at 22.39%, revealing its tax efficiency. The net income per EBT, 77.71%, and the EBT per EBIT, 21.15%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 22.12%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin4.68%
Effective Tax Rate22.39%
Net Income per EBT77.71%
EBT per EBIT21.15%
EBIT per Revenue22.12%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 1.37, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations.

cards.indicatorcards.value
Days of Sales Outstanding123
Days of Inventory Outstanding-1119
Operating Cycle-1079.67
Days of Payables Outstanding117
Cash Conversion Cycle-1197
Receivables Turnover9.39
Payables Turnover3.12
Inventory Turnover-0.33
Fixed Asset Turnover38.59
Asset Turnover1.53

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 15.34, and free cash flow per share, 9.87, depict cash generation on a per-share basis. The cash per share value, 155.85, showcases liquidity position. A payout ratio of 0.23 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, 0.02, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share15.34
Free Cash Flow per Share9.87
Cash per Share155.85
Payout Ratio0.23
Operating Cash Flow Sales Ratio0.02
Free Cash Flow to Operating Cash Flow Ratio0.64
Cash Flow Coverage Ratio0.13
Short Term Coverage Ratio0.80
Capital Expenditure Coverage Ratio2.80
Dividend Paid and Capex Coverage Ratio1.32
Dividend Payout Ratio0.01

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 23.64%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.65, we discern the balance between debt and equity financing. The long-term debt to capitalization, 35.11%, and total debt to capitalization, 39.44%, ratios shed light on its capital structure. An interest coverage of 36.39 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio23.64%
Debt Equity Ratio0.65
Long Term Debt to Capitalization35.11%
Total Debt to Capitalization39.44%
Interest Coverage36.39
Cash Flow to Debt Ratio0.13
Company Equity Multiplier2.76

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 726.32, provides a glimpse into top-line earnings distributed across each share. Net income per share, 25.38, reflects the portion of profit attributed to each share. The book value per share, 166.62, represents the net asset value distributed per share, while the tangible book value per share, 16.17, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share726.32
Net Income Per Share25.38
Book Value Per Share166.62
Tangible Book Value Per Share16.17
Shareholders Equity Per Share166.62
Interest Debt Per Share110.85
Capex Per Share-5.49

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 9.42%, indicates top-line expansion, while the gross profit growth, 7.30%, reveals profitability trends. EBIT growth, -100.05%, and operating income growth, -100.05%, offer insights into operational profitability progression. The net income growth, 1.58%, showcases bottom-line expansion, and the EPS growth, 3.34%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth9.42%
Gross Profit Growth7.30%
EBIT Growth-100.05%
Operating Income Growth-100.05%
Net Income Growth1.58%
EPS Growth3.34%
EPS Diluted Growth3.87%
Weighted Average Shares Growth-1.71%
Weighted Average Shares Diluted Growth-2.22%
Dividends per Share Growth15.48%
Operating Cash Flow Growth-4.02%
Free Cash Flow Growth-6.65%
10-Year Revenue Growth per Share199.92%
5-Year Revenue Growth per Share100.54%
3-Year Revenue Growth per Share49.48%
10-Year Operating CF Growth per Share228.33%
5-Year Operating CF Growth per Share127.06%
3-Year Operating CF Growth per Share-19.82%
10-Year Net Income Growth per Share198.96%
5-Year Net Income Growth per Share72.11%
3-Year Net Income Growth per Share39.22%
10-Year Shareholders Equity Growth per Share97.32%
5-Year Shareholders Equity Growth per Share48.46%
3-Year Shareholders Equity Growth per Share25.87%
10-Year Dividend per Share Growth per Share287.12%
5-Year Dividend per Share Growth per Share93.79%
3-Year Dividend per Share Growth per Share55.46%
Receivables Growth11.35%
Inventory Growth-307.10%
Asset Growth5.99%
Book Value per Share Growth10.14%
Debt Growth4.17%
SGA Expenses Growth106.10%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 129,835,004,000, captures the company's total value, considering both debt and equity. Income quality, 1.35, assesses the reliability of reported earnings. The ratio of intangibles to total assets, 32.67%, indicates the value of non-physical assets, and capex to operating cash flow, -16.08%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value129,835,004,000
Income Quality1.35
Intangibles to Total Assets32.67%
Capex to Operating Cash Flow-16.08%
Capex to Revenue-0.76%
Capex to Depreciation-74.27%
Stock-Based Compensation to Revenue0.17%
Graham Number308.46
Return on Tangible Assets8.16%
Graham Net Net-182.92
Working Capital18,238,000,000
Tangible Asset Value3,815,000,000
Net Current Asset Value-9,494,000,000
Invested Capital1
Average Receivables16,954,500,000
Average Payables21,826,000,000
Average Inventory-28,856,500,000
Days Sales Outstanding38
Days Payables Outstanding486
Days of Inventory On Hand-978
ROE0.15%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 3.09, and the price to book ratio, 3.09, reflect the market's valuation relative to the company's book value. The price to sales ratio, 0.73, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 54.52, and price to operating cash flows, 35.11, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio3.09
Price to Book Ratio3.09
Price to Sales Ratio0.73
Price Cash Flow Ratio35.11
Price Earnings to Growth Ratio-4.47
Enterprise Value Multiple2.67
Price Fair Value3.09
Price to Operating Cash Flow Ratio35.11
Price to Free Cash Flows Ratio54.52
Price to Tangible Book Ratio2.83
Enterprise Value to Sales0.76
Enterprise Value Over EBITDA74.57
EV to Operating Cash Flow16.11
Earnings Yield5.38%
Free Cash Flow Yield6.08%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Elevance Health Inc. (ELV) on the NYSE in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 20.072 in 2024.

What is the ticker symbol of Elevance Health Inc. stock?

The ticker symbol of Elevance Health Inc. stock is ELV.

What is company IPO date?

IPO date of Elevance Health Inc. is 2001-10-30.

What is company current share price?

Current share price is 515.830 USD.

What is stock market cap today?

The market cap of stock today is 120017650270.000.

What is PEG ratio in 2024?

The current -4.471 is -4.471 in 2024.

What is the number of employees in 2024?

In 2024 the company has 104900.